With explosive demand, expanding indications, and rapid innovation, the GLP-1 revolution is reshaping dealmaking. Here's a practical guide for companies negotiating M&A in this arena.
- Developing Exosome-Based RNA Therapeutics For CNS Regeneration
- CMC For Long-Acting Injectables For TB
- Drug Delivery Product Strategy: Aligning The Organization For Execution
- EU MDR: When Products Without An Intended Medical Purpose Meet Medicinal Substances
- The Companion Diagnostic Strategy That Combination Product Leaders Need
- Beyond The Inhaler: Expanding COPD Care With Nebulized Combination Therapy
- 7 Management Strategies For Combination Product Regulatory Success
- Avoiding Alcohol-Induced Dose Dumping In Oral Drug Formulation
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Nasal Vaccine Development, Manufacturing, And Device Selection
When developing a nasal delivery program, a partner with experience in development and manufacturing techniques who can see a program through small-scale clinical to commercial supply is crucial.
-
The Role Of The Contract Manufacturer In Medical Device Development
With a trusted contract manufacturing partner, pharma companies can ensure that their innovative therapies come to market efficiently without compromising the quality of the drug and its delivery system.
-
'Smart Devices' vs. 'Smart Design' In User-Centric Autoinjector Design
Oval Medical has developed a novel Prefilled Primary Drug Container that resolves many drug compatibility and functionality issues associated with the use of traditional glass syringe and rubber plunger technologies.
-
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products
Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.
-
How Approved Drugs Have Evolved Since The '70s
Drugs have become more lipophilic and complex in structure over time. Innovative strategies are needed to improve the bioavailability of these new drugs.
-
Less Mess, Less Stress, Best Expressed: An Alternative To Spray Drying
Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.
-
Oncolytic Viruses Development And cGMP Manufacturing − Experience Matters
Learn more about the leading oncolytic viruses, the leading cell lines, and how to strategize your oncolytic virus production plan.
-
Q&A: Navigating PFAS In Medical Devices
Explore how PFAS in medical devices pose environmental and health concerns, prompting regulatory scrutiny.
-
2R Vials And Deep Cold Storage - Determining Mechanical & CCI Performance
Review the implications of this study on the storage of sensitive molecules that require deep-cold storage and learn how 2R Fina glass vials are poised to enhance cold storage practices.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.

Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:
FRANKLY FRAN
-
In this article, Fran DeGrazio recounts the evolution of drug delivery technologies as she underscores the need to innovate in the delivery of advanced therapies. Considering chronic diseases, rare diseases, and difficult-to-reach therapeutic targets, Fran offers suggestions for organizing and readying for the development and delivery of platforms, systems, and devices for next generation treatments, including personalized, precision medicines.

